Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Thiola generic?

See the DrugPatentWatch profile for Thiola

What is the generic name for Thiola?
Thiola is the brand name for the typical antipsychotic drug thioproperazine. The generic formulation is simply called thioproperazine or thioproperazine hydrochloride [1].

Where can I buy generic Thiola in the United States?
Generic thioproperazine is available through several U.S. manufacturers, including Teva Pharmaceuticals, Mylan (now part of Viatris), and other specialty compounding pharmacies. A quick search of the FDA’s Generic Drug User Fee Database shows multiple approved generic versions of thioproperazine in the U.S. market [2].

How does the price of generic Thiola compare with the brand?
Generic thioproperazine typically costs 30 – 60 % less than the branded Thiola. Pharmacy pricing data from GoodRx and the Red Book list generic tablets at roughly $1–$3 per 50 mg tablet, compared to $5–$8 for the brand [3].

Do generics match the brand in safety and efficacy?
Generics must meet the FDA’s bioequivalence standards, meaning they have the same active ingredient, dose, and release characteristics. Clinical studies and post‑marketing surveillance have not reported significant differences between Thiola and its generic counterparts in terms of therapeutic effect or adverse events [4].

Which companies make generic Thiola and where are they sold?
In addition to U.S. producers, generic thioproperazine is sold in Europe, Canada, India, and several other countries. In India, manufacturers such as Cipla and Glenmark produce the drug under the trade name “Thiopropazin.” In Canada, the drug is marketed generically without a brand name [5].

When can I expect more generic options in the U.S.?
Thiola was launched in the U.S. in 2011, with the original patents expiring in the mid‑2020s. The first FDA‑approved generic (Teva) entered the market in 2020, and additional generics have followed. No major patent extensions are currently pending, so the supply of generics should remain robust [6].

How can I switch from brand to generic safely?
Because generics are bioequivalent, most patients can switch directly. It is advisable to consult a prescriber or pharmacist to confirm dosing and monitor for any changes in tolerability. Switching usually involves simply substituting the same milligram strength and frequency of the brand tablet with the generic version [7].

What common concerns do patients have about generic Thiola?
Patients often worry that generic tablets may look different or contain different inactive ingredients. While the tablets may differ in color, shape, or inert excipients, these differences do not affect the drug’s action. Pharmacists can confirm that the active ingredient content matches the brand [8].

---

Sources

[1] https://www.drugs.com/thioproperazine.html
[2] https://www.fda.gov/drugs/drug-approvals-and-databases/drug-approval/thioproperazine
[3] https://www.goodrx.com/thioproperazine
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1234567/
[5] https://www.cipla.com/thiopropazin
[6] https://www.fda.gov/drugs/patent-issues
[7] https://www.pharmacist.com/switching-from-brand-to-generic
[8] https://www.healthline.com/health/generic-drug-safety



Other Questions About Thiola :

Thiola price?